Renalytix PLC (RNLX)
0.495
-0.02
(-4.01%)
USD |
NASDAQ |
May 21, 10:39
Renalytix Market Cap: 36.52M for May 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 20, 2024 | 38.04M |
| May 17, 2024 | 37.85M |
| May 16, 2024 | 43.44M |
| May 15, 2024 | 41.83M |
| May 14, 2024 | 49.06M |
| May 13, 2024 | 45.67M |
| May 10, 2024 | 45.52M |
| May 09, 2024 | 46.73M |
| May 08, 2024 | 47.29M |
| May 07, 2024 | 50.98M |
| May 06, 2024 | 50.89M |
| May 03, 2024 | 51.65M |
| May 02, 2024 | 55.99M |
| May 01, 2024 | 58.28M |
| April 30, 2024 | 51.11M |
| April 29, 2024 | 43.11M |
| April 26, 2024 | 40.10M |
| April 25, 2024 | 39.81M |
| April 24, 2024 | 40.12M |
| April 23, 2024 | 44.15M |
| April 22, 2024 | 47.11M |
| April 19, 2024 | 50.61M |
| April 18, 2024 | 49.54M |
| April 17, 2024 | 52.38M |
| April 16, 2024 | 52.03M |
| Date | Value |
|---|---|
| April 15, 2024 | 52.05M |
| April 12, 2024 | 55.16M |
| April 11, 2024 | 55.64M |
| April 10, 2024 | 51.18M |
| April 09, 2024 | 50.90M |
| April 08, 2024 | 48.03M |
| April 05, 2024 | 47.97M |
| April 04, 2024 | 46.98M |
| April 03, 2024 | 48.50M |
| April 02, 2024 | 50.96M |
| April 01, 2024 | 49.48M |
| March 28, 2024 | 51.56M |
| March 27, 2024 | 54.56M |
| March 26, 2024 | 52.98M |
| March 25, 2024 | 54.36M |
| March 22, 2024 | 59.16M |
| March 21, 2024 | 55.22M |
| March 20, 2024 | 54.56M |
| March 19, 2024 | 59.96M |
| March 18, 2024 | 62.36M |
| March 15, 2024 | 51.56M |
| March 14, 2024 | 52.70M |
| March 13, 2024 | 40.22M |
| March 12, 2024 | 45.43M |
| March 11, 2024 | 56.96M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
12.97M
Minimum
Jan 19 2024
1.256B
Maximum
Jul 28 2021
368.63M
Average
158.35M
Median
Market Cap Benchmarks
| TC BioPharm (Holdings) PLC | 5.539M |
| Ainos Inc | 6.284M |
| Aptorum Group Ltd | 24.89M |
| Adaptimmune Therapeutics PLC | 281.12M |
| Biodexa Pharmaceuticals Plc | 10.17M |
Market Cap Related Metrics
| PS Ratio | 10.70 |
| Price | 0.495 |
| Earnings Yield | -157.6% |